Stocks of Note for Dec-10 Morning

These stocks are making interesting moves on high volume.

Active Stocks Moving Up Today

Ranger Energy Services Inc. Class A (RNGR) < (RNGR) is currently trading at $4.03 + 0.31 (8.33%). Ranger Energy Services Inc. Class A (RNGR) < is +37.76% for the past 30 days, -37.42% year-to-date, and -41.22% over the last 12 months.

Ranger Energy Services Inc is a provider of high-spec well service rigs and associated services in the United States, with a focus on technically demanding unconventional horizontal well completion and production operations.

DiaMedica Therapeutics Inc. (DMAC) < (DMAC) is currently trading at $6.90 + 0.70 (11.29%). DiaMedica Therapeutics Inc. (DMAC) < is +63.59% for the past 30 days, +42.27% year-to-date, and +132.21% over the last 12 months.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the business activity of developing treatments for unmet clinical need or where no therapies are available with the focus on neurological and kidney diseases.

Panbela Therapeutics Inc. (PBLA) < (PBLA) is currently trading at $4.96 + 0.5857 (13.40%). Panbela Therapeutics Inc. (PBLA) < is +61.54% for the past 30 days, +17.99% year-to-date, and +2.67% over the last 12 months.

Sun BioPharma Inc is a clinical stage drug development company. It is engaged in the commercial development of a proprietary polyamine analogue for pancreatic cancer and for a second indication in chronic pancreatitis.

Leap Therapeutics Inc. (LPTX) < (LPTX) is currently trading at $2.06 + 0.2201 (11.96%). Leap Therapeutics Inc. (LPTX) < is +22.24% for the past 30 days, +83.94% year-to-date, and +138.51% over the last 12 months.

Leap Therapeutics Inc is a biopharmaceutical company . The company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

Anixa Biosciences Inc. (ANIX) < (ANIX) is currently trading at $4.00 + 1.11 (38.41%). Anixa Biosciences Inc. (ANIX) < is +150.25% for the past 30 days, +21.95% year-to-date, and +29.64% over the last 12 months.

ITUS Corp is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers.

ClearOne Inc. (CLRO) < (CLRO) is currently trading at $2.61 + 0.32 (13.97%). ClearOne Inc. (CLRO) < is +69.51% for the past 30 days, +57.23% year-to-date, and +48.11% over the last 12 months.

ClearOne Inc designs, develops and sells conferencing, collaboration, streaming and digital signage solutions for audio\/voice and visual communication. Its products inlcude Digital Signage, Media Carts, Microphone , and UC Voice.

Biocept Inc. (BIOC) < (BIOC) is currently trading at $5.52 + 0.8213 (17.47%). Biocept Inc. (BIOC) < is +22.28% for the past 30 days, +93.05% year-to-date, and +101.33% over the last 12 months.

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.

ZK International Group Co. Ltd (ZKIN) < (ZKIN) is currently trading at $2.28 + 0.2282 (11.13%). ZK International Group Co. Ltd (ZKIN) < is +23.46% for the past 30 days, +76.60% year-to-date, and +75.33% over the last 12 months.

ZK International Group Co Ltd is engaged in designing and producing pipes and fittings such as double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings and single-press tubes and fittings.

SELLAS Life Sciences Group Inc. (SLS) < (SLS) is currently trading at $7.50 + 1.11 (17.43%). SELLAS Life Sciences Group Inc. (SLS) < is +196.40% for the past 30 days, +74.50% year-to-date, and +75.84% over the last 12 months.

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S and NeuVax.

UTStarcom Holdings Corp (UTSI) < (UTSI) is currently trading at $2.06 + 0.7298 (54.87%). UTStarcom Holdings Corp (UTSI) < is +115.96% for the past 30 days, -30.18% year-to-date, and -31.42% over the last 12 months.

UTStarcom Holdings Corp is a telecom infrastructure provider. The company is engaged in developing technology that will serve the rapidly growing demand for bandwidth from mobile, streaming and other applications.

Active Stocks Moving Down Today

Crown Crafts Inc. (CRWS) < (CRWS) is currently trading at $7.48 – 0.33 (4.23%). Crown Crafts Inc. (CRWS) < is +20.90% for the past 30 days, +21.63% year-to-date, and +6.58% over the last 12 months.

Crown Crafts Inc through its subsidiaries operates in the infant and toddler products segment within the consumer products industry. It designs and distributes, infant and toddler bedding and blankets, bibs, disposable products and accessories.

StoneX Group Inc. (SNEX) < (SNEX) is currently trading at $55.98 – 7.15 (11.33%). StoneX Group Inc. (SNEX) < is -7.83% for the past 30 days, +14.64% year-to-date, and +37.13% over the last 12 months.

INTL FCStone Inc is a financial services organization. It is engaged in providing financial products and advisory and execution services that help its clients access market liquidity, maximize profits and manage risk.

Compass Minerals Intl Inc (CMP) < (CMP) is currently trading at $59.77 – 4.16 (6.51%). Compass Minerals Intl Inc (CMP) < is -5.36% for the past 30 days, -1.95% year-to-date, and +6.93% over the last 12 months.

Compass Minerals International Inc is associated with the mining industry. It produces minerals, including salt, sulfate of potash specialty fertilizer and magnesium chloride.

Investcorp Credit Management BDC Inc. (ICMB) < (ICMB) is currently trading at $4.23 – 0.55 (11.51%). Investcorp Credit Management BDC Inc. (ICMB) < is +10.39% for the past 30 days, -36.87% year-to-date, and -40.04% over the last 12 months.

CM Finance Inc is an externally managed, non-diversified closed-end management investment company. It is a specialty finance company that invests in the debt of U.S. middle-market companies.

Protagonist Therapeutics Inc. (PTGX) < (PTGX) is currently trading at $20.89 – 2.55 (10.88%). Protagonist Therapeutics Inc. (PTGX) < is -6.71% for the past 30 days, +196.31% year-to-date, and +178.70% over the last 12 months.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

Comtech Telecommunications Corp. (CMTL) < (CMTL) is currently trading at $18.00 – 1.97 (9.86%). Comtech Telecommunications Corp. (CMTL) < is +4.46% for the past 30 days, -49.28% year-to-date, and -49.04% over the last 12 months.

Comtech Telecommunications Corp is engaged in designing, developing, producing and marketing products, systems and services for communications solutions. It is engaged in two business segments, Commercial Solutions and Government Solutions Segment.

Leaf Group Ltd. (LEAF) < (LEAF) is currently trading at $4.40 – 1.1989 (21.41%). Leaf Group Ltd. (LEAF) < is -18.44% for the past 30 days, +10.03% year-to-date, and +18.38% over the last 12 months.

Leaf Group Ltd is a diversified internet company that builds platforms across its marketplace and media properties to enable communities of creators to reach audiences in large and growing lifestyle categories.

Xenetic Biosciences Inc. (XBIO) < (XBIO) is currently trading at $2.50 – 0.67 (21.14%). Xenetic Biosciences Inc. (XBIO) < is +177.53% for the past 30 days, +73.61% year-to-date, and +75.38% over the last 12 months.

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics.

AquaBounty Technologies Inc. (AQB) < (AQB) is currently trading at $6.80 – 1.8689 (21.56%). AquaBounty Technologies Inc. (AQB) < is +68.14% for the past 30 days, +213.41% year-to-date, and +225.49% over the last 12 months.

AquaBounty Technologies Inc is a biotechnology company. The company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins.